The project
BRAVꓱ at a glance
Computational biomechanics and bioengineering 3D printing to develop a personalised regenerative biological ventricular assist device to provide lasting functional support to damaged hearts.
The BRAVꓱ project aims to develop a regenerative treatment for ischemic heart disease (IHD): an innovative biological ventricular assist device (BioVAD). It is a scaffold that is disposed over the injured area and helps the cardiac cells to make the contraction force needed for an adequate pumping. BRAVꓱ will develop a tailored structure that will be seeded with human induced pluripotent stem cells (hiPSCs), creating cardiac tissue that will be integrated in the patient’s heart.
This approach aims to replace current ventricular assist devices (VADs) to provide temporal functional support to damaged hearts but can’t replace the function of the lost cardiac muscle.
As IHD is the leading single cause of death in the European Union, this approach aims to improve the patient’s quality of life with a single intervention.
The project in numbers
Gender Balance
Impacts
Project structure
General Assembly

FELIPE PROSPER
Universidad de Navarra

JÜRGEN GROLL
University Hospital Würzburg

NURIA MONSERRAT
Fundacio Institut de Bioenginyeria
de Catalunya

MANUEL DOBLARÉ
Universidad de Zaragoza

PETER BOVENDEERD
Technische Universiteit
Eindhoven

Fº FERNANDEZ-AVILÉS
Servicio Madrileño de Salud

PAULA ALVES
Instituto de Biologia
Experimental e Tecnologica

PEDRO MOREO
EBERS Medical Technology

STEFAN JANSSENS
Katholieke Universiteit Leuven

JOS MALDA
Universitair Medisch Centrum Utrecht

ANE M. ZALDÚA
Leartiker

AIDEN FLANAGAN
Boston Scientific

JOHANNES PAULIDES
AE Medicalis

JEANETT BOLTHER
PNO Innovation
Steering Committee

FELIPE PROSPER
Universidad de Navarra

JÜRGEN GROLL
University Hospital Würzburg

NURIA MONSERRAT
Fundacio Institut de Bioenginyeria
de Catalunya

ANE M. ZALDÚA
Leartiker

PETER BOVENDEERD
Technische Universiteit
Eindhoven

STEFAN JANSSENS
Katholieke Universiteit Leuven

PAULA ALVES
Instituto de Biologia
Experimental e Tecnologica

JEANETT BOLTHER
PNO Innovation
Innovation & Exploitation Committee

FELIPE PROSPER
Universidad de Navarra

STEFAN JANSSENS
Katholieke Universiteit Leuven

JÜRGEN GROLL
University Hospital Würzburg

PAULA ALVES
Instituto de Biologia
Experimental e Tecnologica

NURIA MONSERRAT
Fundacio Institut de Bioenginyeria
de Catalunya

PETER BOVENDEERD
Technische Universiteit
Eindhoven

JEANETT BOLTHER
PNO Innovation

ANA ESPERT
PNO Innovation

AIDEN FLANAGAN
Boston Scientific

JOHANNES PAULIDES
AE Medicalis

OSCAR GONZÁLEZ
Universidad de Navarra
External Advisory Board

PHILIPPE MENASCHÉ
Hôpital Européen Georges-Pompidou

ELENA DE JUAN
The University of Western Australia

MAXIME SERMESANT
Université Côte D’Azur

CARLIJN BOUTEN
Technische Universiteit Eindhoven

ANA ARANDA
Servicio Murciano de Salud

ANTONIO PARDO
Universidad de Navarra

TOMAS FAJARDO
CardioAlianza